Samsrita Labs Ltd Stock Price Today (NSE: SAMSRITA)
Fundamental Score
Samsrita Labs Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Samsrita Labs Ltd share price today is ₹17.39, up +0.00% on NSE/BSE as of 18 February 2026. Samsrita Labs Ltd (SAMSRITA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹48.45 (Cr). The 52-week high for SAMSRITA share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -2.31% and a debt-to-equity ratio of 0.11.
Samsrita Labs Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Samsrita Labs Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Samsrita Labs Share Price: A Conservative Value Investor's Perspective
In the dynamic healthcare service provider industry, characterized by evolving diagnostic technologies and shifting patient demographics, companies face constant pressure to innovate and maintain profitability. This analysis examines the fundamentals influencing the Samsrita Labs share price from the perspective of a conservative value investor prioritizing capital safety. Given the current market volatility, a rigorous assessment of financial health and competitive positioning is crucial.
Currently, Samsrita Labs Ltd presents a challenging profile. The reported Return on Capital Employed (ROCE) of -1.8% is a significant concern. ROCE measures how effectively a company generates profits from its capital. A negative ROCE suggests that the company is destroying value rather than creating it. This substantially weakens any potential economic moat, making it difficult for Samsrita Labs to sustain a competitive advantage over the long term.
Furthermore, the absence of a Price-to-Earnings (PE) ratio indicates that the company is not currently profitable, further emphasizing the need for caution. Comparing Samsrita Labs with its peers, such as
Suraksha Diagnostic Ltd, highlights potential differences in management quality and operational efficiency. While both companies operate within the diagnostics sector, their financial performance and strategic direction may vary significantly. A deeper dive into Suraksha's leadership and capital allocation strategies would offer insights into best practices within the industry, and a point of contrast against Samsrita Labs.From a value investing standpoint, a -1.8% ROCE raises serious questions about the sustainability of Samsrita Labs' business model. It necessitates a thorough investigation into the underlying causes, such as operational inefficiencies, high debt levels, or inadequate pricing strategies. This analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, focused on assessing the intrinsic value and risk profile of the company. Note that this is purely an observational analysis and does not constitute any form of investment recommendation.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Samsrita Labs Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SAMSRITA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (-2.31%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.80%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Negative Free Cash Flow (₹-0.67 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Samsrita Labs Ltd Financial Statements
Comprehensive financial data for Samsrita Labs Ltd including income statement, balance sheet and cash flow
About SAMSRITA (Samsrita Labs Ltd)
Samsrita Labs Ltd (SAMSRITA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹48.45 (Cr). Samsrita Labs Ltd has delivered a Return on Equity (ROE) of -2.31% and a ROCE of -1.80%. The debt-to-equity ratio stands at 0.11, reflecting the company's capital structure. Investors tracking SAMSRITA share price can monitor key metrics including P/E ratio, promoter holding of 31.41%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
SAMSRITA Share Price: Frequently Asked Questions
What is the current share price of Samsrita Labs Ltd (SAMSRITA)?
As of 18 Feb 2026, 10:41 am IST, Samsrita Labs Ltd share price is ₹17.39. The SAMSRITA stock has a market capitalisation of ₹48.45 (Cr) on NSE/BSE.
Is SAMSRITA share price Overvalued or Undervalued?
SAMSRITA share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 39.28x. Based on this relative valuation, the Samsrita Labs Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of SAMSRITA share price?
The 52-week high of SAMSRITA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Samsrita Labs Ltd share price?
Key factors influencing SAMSRITA share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Samsrita Labs Ltd a good stock for long-term investment?
Samsrita Labs Ltd shows a 5-year Profit Growth of 13.20% and an ROE of -2.31%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing in SAMSRITA shares.
How does Samsrita Labs Ltd compare with its industry peers?
Samsrita Labs Ltd competes with major peers in the Healthcare Service Provider. Investors should compare SAMSRITA share price P/E of 0.00x and ROE of -2.31% against the industry averages to determine competitive standing.
What is the P/E ratio of SAMSRITA and what does it mean?
SAMSRITA share price has a P/E ratio of N/Ax compared to the industry average of 39.28x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is SAMSRITA performing according to Bull Run's analysis?
SAMSRITA has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SAMSRITA belong to?
SAMSRITA operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Samsrita Labs Ltd share price.
What is Return on Equity (ROE) and why is it important for SAMSRITA?
SAMSRITA has an ROE of -2.31%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Samsrita Labs Ltd generates profits from shareholders capital.
How is SAMSRITA debt-to-equity ratio and what does it indicate?
SAMSRITA has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk.
What is SAMSRITA dividend yield and is it a good dividend stock?
SAMSRITA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Samsrita Labs Ltd shares.
How has SAMSRITA share price grown over the past 5 years?
SAMSRITA has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 13.20%, and EPS Growth 13.20%.
What is the promoter holding in SAMSRITA and why does it matter?
Promoters hold 31.41% of SAMSRITA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Samsrita Labs Ltd.
What is SAMSRITA market capitalisation category?
SAMSRITA has a market capitalisation of ₹48 crores, placing it in the Small-cap category.
How volatile is SAMSRITA stock?
SAMSRITA has a beta of N/A. A beta > 1 suggests the Samsrita Labs Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SAMSRITA operating profit margin trend?
SAMSRITA has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is SAMSRITA quarterly performance?
Recent quarterly performance shows Samsrita Labs Ltd YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in SAMSRITA?
SAMSRITA has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Samsrita Labs Ltd stock.